Fungal infections in the ICU

  • A. De Gasperi
  • A. Corti
  • L. Perrone
Conference paper


Data collected over the past 10–20 years clearly show that invasive fungal infections, far from being observed in immunocompromised hosts only, are increasingly recognised as a growing problem in critically ill nonimmunocompromised patients and in subjects undergoing major surgical procedures [1, 2, 3]. While Candida spp. are the most common cause of severe fungal infections in the ICU, mould infections are so far rare, but the problem is rapidly rising due to the increased spectrum of patients at risk for aspergillar infections [4]. According to Vanderwoude [5], this particular group of patients has recently been categorised into different risk classes: high risk (allogeneic bone marrow-transplanted patients, neutropenic and haematological patients); intermediate risk (autologous bone marrow-transplanted patients, subjects suffering from malnutrition, under corticosteroid therapy, with diabetes or underlying pulmonary diseases) and low risk (patients suffering for cystic fibrosis and connective tissue disease). Cases of invasive pulmonary aspergillosis have been reported in apparently nonimmunocompromised COPD patients [5].


Total Parenteral Nutrition Invasive Fungal Infection Invasive Candidiasis Candida Infection Antifungal Prophylaxis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill nonimmunosuppressed patients. Lancet Infect Dis 3:685–702PubMedCrossRefGoogle Scholar
  2. 2.
    Svoboda P, Kantarova I (2006) Systemic Candida infection in the ICU. In: Vincent JL (ed): Yearbook of intensive care and emergency medicine. Springer, New York Berlin Heidelberg, pp 595–603CrossRefGoogle Scholar
  3. 3.
    Playford GE, Webster AC, Sorrell TC, Craig JC (2006) Antifungal agents for preventing fungal infections in the non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemioter 57:628–638CrossRefGoogle Scholar
  4. 4.
    Meersseman W, Wilmer A, Peetersman WE (2004) The spectrum of invasive aspergillosis in the ICU: not just for haematology patients. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, New York Berlin Heidelberg, pp 258–264Google Scholar
  5. 5.
    Vandewoude KH, Blot SI, Depuydt P et al (2006) Clinical relevance of Aspergillus isolation from respiratory tract sample in critically ill patients. Crit Care 10:R31 (doi:10.1186/cc4823)PubMedCrossRefGoogle Scholar
  6. 6.
    Tortorano AM, Caspani L, Rigoni AL et al (2004). Candidosis in the ICU: a 20 years survey. J Hosp Infect 57:8–13PubMedCrossRefGoogle Scholar
  7. 7.
    Eggimann P, Calandra T, Flickiger U et al (2005). Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists. Intensive Care Med, 31:1514–1521PubMedCrossRefGoogle Scholar
  8. 8.
    Ostrosky Zeichner L (2003) New approaches to the risk of Candida in the ICUs. Curr Opin Infect Dis 16:533–537PubMedCrossRefGoogle Scholar
  9. 9.
    Martin GS, Mannino DM, Eaton S, Moss M (2003) Epidemiology of sepsis in the US from 1979 through 2000. N Engl J Med 348:1546PubMedCrossRefGoogle Scholar
  10. 10.
    Blumberg HM, Jarvis WR, Soucie M et al (2001) Risk factors for the Candida bloodstream infections in surgical ICUs patients: the NEMIS prospective multicenter study. Clin Infect Dis 33:177–186PubMedCrossRefGoogle Scholar
  11. 11.
    Vincent JL, Bihari DJ, Suter PM et al (1995) The prevalence of nosocomial infection in ICUs in Europe. Results of EPIC Study. JAMA 274:639–644PubMedCrossRefGoogle Scholar
  12. 12.
    Alberti C, Brun-Buisson VC, Burchardi H et al (2003) Epidemiology of sepsis and infarction in ICU patients from an international multicenter cohort study. Intensive Care Med 28:108–121CrossRefGoogle Scholar
  13. 13.
    Leleu G, Aegerter P, Guidet B (2002) Systemic candidiasis in ICU: a multicenter matched cohort study. J Crit Care 17:168–175PubMedCrossRefGoogle Scholar
  14. 14.
    Luzzaro F, Viganò EF, Fossati D et al (2002) Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two years study in 16 hospitals. Eur J Clin Microbiol Dis 21:849–855Google Scholar
  15. 15.
    Tortorano A, Kibbler C, Peman A et al (2006) Candidemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359–366PubMedCrossRefGoogle Scholar
  16. 16.
    Marchetti O, Bille J, Fluckinger U et al (2004) Epidemiology of Candida in Swiss tertiary care hospital: secular trends 1991–2000. Clin Infect Dis 38:311–320PubMedCrossRefGoogle Scholar
  17. 17.
    Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758PubMedCrossRefGoogle Scholar
  18. 18.
    Edwards J (1997) International conference on the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 25:43–59PubMedCrossRefGoogle Scholar
  19. 19.
    Snydman DR (2003) Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 123:500S–503SPubMedCrossRefGoogle Scholar
  20. 20.
    Tortorano C, Peman A, Bernhardt A and the ECMM Working group on Candidemia (2004) Epidemiology of candidemia in Europe: results of 28 months ECMM hospitalbased surveillance study. Eur J Clin Microbiol Infect Dis 23:317–322PubMedCrossRefGoogle Scholar
  21. 21.
    Eggimann P, Pittet D (2006) Candida colonization index in the management of critically ill patients. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, New York Berlin Heidelberg, pp 604–612CrossRefGoogle Scholar
  22. 22.
    Lipsett P (2002) Fungal infections in surgical patients. Prob Gen Surg 19:92–102CrossRefGoogle Scholar
  23. 23.
    Eggimann P, Garbino J, Pittet D (2003) Management of Candida species infections in critically ill non immunosuppressed patients. Lancet Infect Dis 3:772–785PubMedCrossRefGoogle Scholar
  24. 24.
    Pappas PG, Rex JH, Sobel JD et al (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38:161–189PubMedCrossRefGoogle Scholar
  25. 25.
    Rex JH, Sobel JD(2001) Prophylactic antifungal therapy in ICU. Clin Infect Dis 32:1191–1200PubMedCrossRefGoogle Scholar
  26. 26.
    Blot S, Vanderwoude K (2004) Management of invasive candidiasis in critically ill patients. Drugs 64:2159–2171PubMedCrossRefGoogle Scholar
  27. 27.
    Jones BL, McLintock AL (2003) Impact of diagnostic markers on early antifungal therapy. Curr Opin Infect Dis 16:521–526PubMedCrossRefGoogle Scholar
  28. 28.
    Leon C, Ruiz Santana S, Saavedra P et al (2006) A bedside scoring system (Candida scoring system) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • A. De Gasperi
    • 1
  • A. Corti
    • 1
  • L. Perrone
    • 1
  1. 1.2nd Anaesthesia, Intensive Care and Abdominal Transplantation UnitNiguarda Ca’Granda HospitalMilanItaly

Personalised recommendations